Skip to content

The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic

The Importance of Needle Gauge for Pain During Injection of Local Anaesthetic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02107729
Enrollment
36
Registered
2014-04-08
Start date
2014-02-28
Completion date
2014-06-30
Last updated
2016-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Needlestick Injuries

Keywords

Injections, Pain, Healthy volunteers, Lidocaine

Brief summary

This study will investigate the influence of needle gauge on pain during injection of local anaesthetic. Healthy volunteers will be recruited, who will each receive three injections with either 21G, 23G or 27G subcutaneously on the abdomen. After each injection, the participants will be asked to evaluate the pain on a Visual analog scale (0-100 mm). It is anticipated that the pain will decrease with decreasing thickness of the needle. The aim of this study is to find a simple method for pain reduction that can be used in clinical practice.

Interventions

PROCEDURELarge needle gauge lidocaine injection

21 G

PROCEDURENormal needle gauge lidocaine injection

23 G

PROCEDURESmall needle gauge lidocaine injection

27 G

Sponsors

St. Olavs Hospital
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18-65 years

Exclusion criteria

* Kidney, heart or liver disease * Eczema or psoriasis on injection site * Neuropathy * Regular use of painkillers * Hypersensitivity of Lidocaine * Pregnancy * Diabetes

Design outcomes

Primary

MeasureTime frameDescription
Pain60 seconds1. Visual analog scale 2. Questionnaire

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026